LASAGNA, ANGIOLETTA

LASAGNA, ANGIOLETTA  

Mostra records
Risultati 1 - 20 di 33 (tempo di esecuzione: 0.036 secondi).
Titolo Data di pubblicazione Autore(i) File
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 1-gen-2021 Lasagna, A.; Agustoni, F.; Percivalle, E.; Borgetto, S.; Paulet, A.; Comolli, G.; Sarasini, A.; Bergami, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Arena, F.; Lilleri, D.; Secondino, S.; Falzoni, M.; Schiavo, R.; Klersy, C.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 1-gen-2021 Lasagna, A; Agustoni, F; Percivalle, E; Borgetto, S; Paulet, A; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Lilleri, D; Secondino, S; Falzoni, M; Schiavo, R; Klersy, C; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 1-gen-2022 Lasagna, A.; Lilleri, D.; Agustoni, F.; Percivalle, E.; Borgetto, S.; Alessio, N.; Comolli, G.; Sarasini, A.; Bergami, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Arena, F.; Secondino, S.; Falzoni, M.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 1-gen-2022 Lasagna, A; Lilleri, D; Agustoni, F; Percivalle, E; Borgetto, S; Alessio, N; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Secondino, S; Falzoni, M; Schiavo, R; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 1-gen-2021 Di Cosimo, Serena; Tagliaferri, Barbara; Generali, Daniele; Giudici, Fabiola; Agustoni, Francesco; Bernardo, Antonio; Borgonovo, Karen; Farina, Gabriella; Luchena, Giovanna; Luciani, Andrea; Nolè, Franco; Palmeri, Laura; Pietrantonio, Filippo; Poggi, Guido; Zucali, Paolo Andrea; Balletti, Emanuela; Catania, Giovanna; Bernocchi, Ottavia; D'Antonio, Federica; Giordano, Monica; Grossi, Francesco; Lasagna, Angioletta; La Verde, Nicla; Manzoni, Mariangela; Montagna, Benedetta; Olgiati, Angelo; Raimondi, Alessandra; Rampinelli, Irene; Verri, Elena; Zaniboni, Alberto; Di Maio, Massimo; Beretta, Giordano; Danova, Marco
Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir 1-gen-2022 Lasagna, Angioletta; Piralla, Antonio; Secondino, Simona; Sacchi, Paolo; Baldanti, Fausto; Bruno, Raffaele; Pedrazzoli, Paolo
COVID-19 and breast cancer: May the microbiome be the issue? 1-gen-2021 Lasagna, A.; Zuccaro, V.; Ferraris, E.; Corbella, M.; Bruno, R.; Pedrazzoli, P.
Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment 1-gen-2022 Lasagna, Angioletta; Cassaniti, Irene; Lilleri, Daniele; Quaccini, Mattia; Ferrari, Alessandra; Sacchi, Paolo; Bruno, Raffaele; Baldanti, Fausto; Pedrazzoli, Paolo
G-CSF and G-CSF-related vasculitis: A systematic review of the literature and intriguing future research perspectives 1-gen-2021 Muzzana, M.; Pedrazzoli, P.; Lasagna, A.
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors 1-gen-2022 Serra, F.; Cassaniti, I.; Lilleri, D.; Pedrazzoli, P.; Baldanti, F.; Lasagna, A.
How to use prophylactic G-CSF in the time of COVID-19 1-gen-2020 Lasagna, A.; Zuccaro, V.; Ferraris, E.; Rizzo, G.; Tancredi, R. J.; Pedrazzoli, P.
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 1-gen-2022 Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 1-gen-2022 Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Alessio, N.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Secondino, S.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
Infectious complications and immunotherapy: old pitfalls and new horizons 1-gen-2022 Lasagna, Angioletta; Cassaniti, Irene; Sacchi, Paolo; Baldanti, Fausto; Bruno, Raffaele; Pedrazzoli, Paolo
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research 1-gen-2021 Lasagna, A.; Muzzana, M.; Pedrazzoli, P.
Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience 1-gen-2023 Lasagna, Angioletta; Albi, Giuseppe; Figini, Simone; Basile, Sara; Sacchi, Paolo; Bruno, Raffaele; Pedrazzoli, Paolo
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 1-gen-2019 Garcia-Etienne, C. A.; Ferrari, A.; Della Valle, A.; Lucioni, M.; Ferraris, E.; Di Giulio, G.; Squillace, L.; Bonzano, E.; Lasagna, A.; Rizzo, G.; Tancredi, R.; Scotti Foglieni, A.; Dionigi, F.; Grasso, M.; Arbustini, E.; Cavenaghi, G.; Pedrazzoli, P.; Filippi, A. R.; Dionigi, P.; Sgarella, A.
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study 1-gen-2023 Lasagna, Angioletta; Albi, Giuseppe; Maserati, Renato; Zuccarini, Andrea; Quaccini, Mattia; Baldanti, Fausto; Sacchi, Paolo; Bruno, Raffaele; Pedrazzoli, Paolo
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 1-gen-2023 Lasagna, Angioletta; Cassaniti, Irene; Arena, Francesca; Bergami, Federica; Percivalle, Elena; Comolli, Giuditta; Sarasini, Antonella; Ferrari, Alessandro; Cicognini, Daniela; Schiavo, Roberta; Lo Cascio, Giuliana; Pedrazzoli, Paolo; Baldanti, Fausto
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? 1-gen-2021 Lucioni, M.; Rossi, C.; Lomoro, P.; Ballati, F.; Fanizza, M.; Ferrari, A.; Garcia-Etienne, C. A.; Boveri, E.; Meloni, G.; Sommaruga, M. G.; Ferraris, E.; Lasagna, A.; Bonzano, E.; Paulli, M.; Sgarella, A.; Di Giulio, G.